Growth Metrics

Merck (MRK) Other Working Capital Changes (2016 - 2026)

Merck has reported Other Working Capital Changes over the past 18 years, most recently at $1.6 billion for Q1 2026.

  • Quarterly Other Working Capital Changes fell 56.55% to $1.6 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.2 billion through Mar 2026, down 30.81% year-over-year, with the annual reading at $3.3 billion for FY2025, 133.55% up from the prior year.
  • Other Working Capital Changes was $1.6 billion for Q1 2026 at Merck, up from -$1.4 billion in the prior quarter.
  • Over five years, Other Working Capital Changes peaked at $3.7 billion in Q1 2025 and troughed at -$2.6 billion in Q3 2024.
  • The 5-year median for Other Working Capital Changes is $1.0 billion (2024), against an average of $595.5 million.
  • Year-over-year, Other Working Capital Changes tumbled 1031.43% in 2024 and then skyrocketed 123.22% in 2025.
  • A 5-year view of Other Working Capital Changes shows it stood at -$962.0 million in 2022, then soared by 96.36% to -$35.0 million in 2023, then tumbled by 1031.43% to -$396.0 million in 2024, then crashed by 240.91% to -$1.4 billion in 2025, then surged by 219.48% to $1.6 billion in 2026.
  • Per Business Quant, the three most recent readings for MRK's Other Working Capital Changes are $1.6 billion (Q1 2026), -$1.4 billion (Q4 2025), and -$1.3 billion (Q3 2025).